These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 4385733

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E.
    Airenne AL, Westermarck T.
    Med Biol; 1984; 62(2):154. PubMed ID: 6471936
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Results with tocopheryl phosphate and inositol therapy of Erb's progressive muscular dystrophy].
    BECKMANN R.
    Dtsch Z Nervenheilkd; 1951; 167(1):17-30. PubMed ID: 14926441
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment problems using anabolic steroids in progressive muscular dystrophy].
    Badalian LO, Temin PA, Mukhin KIu.
    Klin Med (Mosk); 1984 Nov; 62(11):23-9. PubMed ID: 6394898
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Potassium-magnesium-aspartate in the therapy of heart diseases].
    Lordick H.
    Med Welt; 1968 Aug 24; 33():1790-7. PubMed ID: 5732182
    [No Abstract] [Full Text] [Related]

  • 29. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M.
    Arzneimittelforschung; 1965 Jul 24; 15(7):782-5. PubMed ID: 5898681
    [No Abstract] [Full Text] [Related]

  • 30. [Experience with the modification of experimental myopathy by an anabolic substance].
    Kaeser HE, Wüthrich R.
    Med Pharmacol Exp Int J Exp Med; 1967 Jul 24; 16(4):365-70. PubMed ID: 5631049
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T, Annaka S, Baba T, Kanno M.
    Iryo; 1969 Oct 24; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Anabolic steroids and muscular dystrophy.
    Walton.
    Neurology; 1992 Jul 24; 42(7):1435-6. PubMed ID: 1620370
    [No Abstract] [Full Text] [Related]

  • 37. Duchenne's muscular dystrophy.
    Leong LL.
    Med J Aust; 1968 Jul 27; 2(4):190-1. PubMed ID: 5670892
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction].
    Jiang XR, Chen WP, Shi HL, Zhou LF.
    Zhongguo Yao Li Xue Bao; 1984 Mar 27; 5(1):36-9. PubMed ID: 6232818
    [No Abstract] [Full Text] [Related]

  • 39. [On the effect of potassium, magnesium aspartate therapy in various heart diseases].
    Máté K.
    Landarzt; 1967 Apr 10; 43(10):477-81. PubMed ID: 5584425
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.